07.01.2025 • News

Barentz Appoints Derk Jan Terhorst as CEO

Global specialty ingredients solution provider Barentz has appointed Derk Jan Terhorst as group CEO, effective Jan. 1, 2025. He will take over from Terry Hill who served as interim CEO since May 2024.

Terhorst has been with Barentz for more than three years as group CFO. Prior to joining Barentz, he held positions in Ahold Delhaize and Tony’s Chocolonely. Terhorst holds a master’s degree in economics and started his career at General Electric.

According to Barentz, a new CFO has been selected and will start on May 1, 2025. Until then, Terhorst will continue to assume CFO responsibilities.

Barentz appoints Derk Jan Terhorst as CEO effective January 1, 2025. © Barentz
Barentz appoints Derk Jan Terhorst as CEO effective January 1, 2025. © Barentz

Company

Logo:

Barentz

Saturnusstraat 15
2132 HB Hoofddorp
Netherlands

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.